Effect of Fluoxetine on Pharmacokinetics of Ritonavir

The potential interaction between fluoxetine, a known inhibitor of cytochrome P-450 isoform 2D6 (CYP2D6), and ritonavir, a human immunodeficiency virus type 1 protease inhibitor, was evaluated in this open-label study. Sixteen male and female subjects ranging in age from 18 to 40 years completed the...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Ouellet, Daniele, Hsu, Ann, Qian, Jiang, Lamm, Janet E., Cavanaugh, John H., Leonard, John M., Granneman, G. Richard
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1998
Materias:	Pharmacology
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC106007/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9835499/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.12.3107
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!